Atlas FDA

Ikaria INOMAX DS Drug Delivery System, model 10003. Ikaria 6 Route 173, Clinton, NJ 08809 USA. The INOMAX DS Delivery Sy

FDA device recall Z-2176-2010 · posted 2010-08-13 · Terminated

Recall details

Recalling firm
Ikaria Holdings
Reason for recall
The pressure switch in the INOMAX DS drug-delivery system may fail, which may interrupt or delay the administration of INOMAX (nitric oxide) for inhalation to patients. Delay in administration of INOMAX therapy may cause: -worsening of systemic oxygenation indices (i.e., hypoxemia, especially manifested as decreased arterial oxygenation saturation). -hypotension, and/or -increase in pulm
Action taken
Ikaria sent an Urgent Medical Device Recall letter to customers dated July 21, 2010. This letter is also posted on the Inomax webpage. The letter described the issue, how to recognize it, what to do in the event of a suspected leak, and recommended maintaining back-up cylinders and depressurization of the regulator when not in use. The replacement plan for all INOMAX DS drug-delivery systems was described. Customers can contact Ikaria Customer Care at 1-877-566-9466.
Root cause
Component design/selection
Status
Terminated
Product code
MRN
Quantity affected
2507
Distribution
Worldwide Distribution to include: US Nationwide and Countries of Canada and Malaysia
Date initiated
2010-07-21
Date posted
2010-08-13
Date terminated
2011-12-27
Location
Clinton, NJ

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
INO THERAPEUTICS INOMAX DS (DELIVERY SYSTEM), MODEL 10003 (K061901)Ino Therapeutics2006-12-14